Merck to buy Idenix Pharmaceuticals for $3.85B
June 09, 2014 at 09:37 AM EDT
Merck, in a move to expand its portfolio of hepatitis C treatments, has entered into a deal to acquire Idenix Pharmaceuticals Inc...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|